Other studies in animals and humans have found that other supplements may also help promote GLP-1 secretion, potentially contributing to appetite regulation and the management of diabetes and obesity
Both are produced by licensed 503A compounding pharmacies, available across all 50 states without insurance, and HSA/FSA eligible
However, Mounjaro (tirzepatide), a newer GLP-1 agonist for diabetes, does not yet have this indication from the FDA
Shan X, Gong X, Li J, Wen J, Li Y, Zhang Z (2022) Current approaches of nanomedicines in the market and various stage of clinical translation
The unique structural properties of S-Phenylacetyl Glutathione enable it to bypass typical glutathione degradation pathways that occur in extracellular environments
Lee JMS, Robson MD, Yu LM, et al